|
|
|
16 Mar 2010 |
Lantheus Medical Imaging, Inc. Presents Preliminary Phase 2 Data With Flurpiridaz F 18 (BMS747158), a Novel PET Cardiac Imaging Agent, at the American College Of Cardiology 59th Annual Scientific Session
|
- |
|
15 Mar 2010 |
Portola Pharmaceuticals and Merck Announce that Phase 2 Study Showed Investigational Factor Xa Inhibitor, Betrixaban, Reduced Incidence of Bleeding Compared to Warfarin in Patients with Atrial Fibrillation
|
6 |
|
15 Mar 2010 |
Dabigatran etexilate shows greater reductions than warfarin in stroke in patients with atrial fibrillation across all stroke risk groups
|
5 |
|
15 Mar 2010 |
Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
|
1 |
|
14 Mar 2010 |
XOMA 052 Prevents Adverse Cardiac Remodeling in Animal Model of Heart Attack
|
3 |
|
12 Mar 2010 |
Sanofi-aventis and Bristol-Myers Squibb Announce Important Updates to PLAVIX U.S. Prescribing Information
|
7 |
|
12 Mar 2010 |
GlaxoSmithKline receives marketing authorisation in the EU for Revolade (eltrombopag)
|
8 |
|
11 Mar 2010 |
ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer
|
4 |
|
10 Mar 2010 |
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
|
8 |
|
09 Mar 2010 |
Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial
|
6 |
|
09 Mar 2010 |
Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial (SAVOR-TIMI 53)
|
5 |
|
09 Mar 2010 |
Ischemix Initiates Phase 2a Trial of CMX-2043 for the Prevention of Ischemia-Reperfusion Injury
|
5 |
|
05 Mar 2010 |
ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Was Statistically Superior to Enoxaparin in the Prevention of Venous Thromboembolism Following Knee Replacement Surgery
|
10 |
|
02 Mar 2010 |
Pluristem Therapeutics Receives DSMB Approval to Advance to Final Dose Level With PLX-PAD
|
26 |
|
26 Feb 2010 |
Agennix AG Announces Longer-Term Mortality Results From Talactoferrin Phase 2 Trial in Severe Sepsis
|
50 |
|
25 Feb 2010 |
AFFiRiS AG: vaccination against hypertension is development project no. 4 and has already been awarded an FFG grant of up to 1.2 million.
|
13 |
|
24 Feb 2010 |
Aastrom Reports Interim Results From Critical Limb Ischemia Trial
|
8 |
|
23 Feb 2010 |
Forest Laboratories Receives Decision from FDA for Supplemental New Drug Application for Bystolic(R)
|
24 |
|
19 Feb 2010 |
United Therapeutics Corporation Withdraws European Marketing Authorization Application for Tyvaso for the Treatment of Pulmonary Arterial Hypertension
|
45 |
|
18 Feb 2010 |
Biogen Idec and Swedish Orphan Biovitrum Update Hemophilia Partnership Agreement
|
12 |
|
16 Feb 2010 |
Athersys Announces Completion of Patient Enrollment in Phase I Study of Multistem(R) in Acute Myocardial Infarction
|
15 |
|
11 Feb 2010 |
FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16
|
81 |
|
08 Feb 2010 |
US FDA Approves New Indication for CRESTOR(R) (rosuvastatin calcium)
|
39 |
|
04 Feb 2010 |
Bioheart Launches First US FDA Approved Clinical Trial that Tests Gene-Modified Stem Cell Therapy in Patients with Congestive Heart Failure
|
78 |
|
03 Feb 2010 |
APEIRON AND GSK SIGN AN EXCLUSIVE LICENSE AGREEMENT FOR APEIRON'S THERAPEUTIC ENZYME PROJECT APN01
|
23 |
|
03 Feb 2010 |
Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Prevention of Recurrent Venous Thromboembolism
|
26 |
|
01 Feb 2010 |
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
|
37 |
|
28 Jan 2010 |
GTC Provides Recombinant FVIIa Regulatory Update
|
33 |
|
28 Jan 2010 |
First Refractory Angina Patient treated with VEGF-D shortform (EG011) in Phase I/IIa trial
|
58 |
|
26 Jan 2010 |
Cardium Provides Update on Commercial Development Plans for Generx Angiogenic Therapy for Heart Disease at 2010 Cell & Gene Therapy Forum
|
25 |
| |
|
Results 1 - 30 of 1335 |
